Drug–drug interaction study of ciprofol and sodium divalproex: Pharmacokinetics, pharmacodynamics, and safety in healthy Chinese subjects

Ciprofol (also known as HSK3486) is a promising intravenous anesthetic candidate derived from propofol and independently developed by Haisco Pharmaceutical Group Co., Ltd. (Chengdu, China). Compared with propofol, ciprofol has the potential to reduce the dose required and the associated risks. Cipro...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Dandan, Zhang, Wei, Ruan, Zourong, Jiang, Bo, Huang, Siqi, Wang, Jiaying, Zhao, Pengfei, Hu, Mengyue, Yan, Min, Lou, Honggang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582675/
https://www.ncbi.nlm.nih.gov/pubmed/37537949
http://dx.doi.org/10.1111/cts.13605

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10582675/
https://www.ncbi.nlm.nih.gov/pubmed/37537949
http://dx.doi.org/10.1111/cts.13605

Ejemplares similares